subject area of
- 2018 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation Journal Articles
- A Phase 2, randomized, partially blinded, active-controlled study assessing the efficacy and safety of variable anticoagulation reversal using the REG1 system in patients with acute coronary syndromes: results of the RADAR trial Journal Articles
- An open clinical study assessing the efficacy and safety of Factor IX Grifols, a high-purity Factor IX concentrate, in patients with severe haemophilia B. Journal Articles
- Andexanet alfa for the treatment of hemorrhage Journal Articles
- Answering relevant research questions via careful observation of clinical practice: a fresh look at the old way forward Journal Articles
- Antibody-Based Ticagrelor Reversal Agent in Healthy Volunteers Journal Articles
- Antidotes for Novel Oral Anticoagulants Journal Articles
- Benefit and risk of heparin for maintaining peripheral venous catheters in neonates: a placebo-controlled trial Journal Articles
- Central venous access device insertion and perioperative management of patients with severe haemophilia A Journal Articles
- Clinical benefit of steroid use in patients undergoing cardiopulmonary bypass: a meta-analysis of randomized trials Journal Articles
- Comparing bleed frequency and factor concentrate use between haemophilia A and B patients Journal Articles
- Concentrate‐related inhibitor risk: is a difference always real? Journal Articles
- Continuous prophylaxis with recombinant factor IX Fc fusion protein and conventional recombinant factor IX products: comparisons of efficacy and weekly factor consumption Journal Articles
- Current use of biologicals in thrombosis and haemostasis Journal Articles
- Design and rationale for RE-VERSE AD: A phase 3 study of idarucizumab, a specific reversal agent for dabigatran Journal Articles
- Estimating and interpreting the pharmacokinetic profiles of individual patients with hemophilia A or B using a population pharmacokinetic approach: communication from the SSC of the ISTH Journal Articles
- Evaluation of patients’ attitudes towards stroke prevention and bleeding risk in atrial fibrillation Journal Articles
- Factor VIIa gets even bigger Journal Articles
- Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors Journal Articles
- Haemophilia clinical care and research needs: Assessing priorities Journal Articles
- Haemophilia in a real‐world setting: the value of clinical experience in data collection Journal Articles
- Identification of the MMRN1 Binding Region within the C2 Domain of Human Factor V Journal Articles
- Impact of Adopting Population Pharmacokinetics for Tailoring Prophylaxis in Haemophilia A Patients: A Historically Controlled Observational Study Journal Articles
- Inhibitor development in non-severe haemophilia across Europe Journal Articles
- Intracranial Haemorrhage in Patients on Antithrombotics: Clinical Presentation and Determinants of Outcome in a Prospective Multicentric Study in Italian Emergency Departments Journal Articles
-
Large scale studies assessing anti‐factor
VIII antibody development in previously untreated haemophilia A: what has been learned, what to believe and how to learn more Journal Articles - Low Dose Prophylaxis vis-a-vis on-Demand Treatment Strategies for Hemophilia: A Cost Effective and Disability Attenuating Approach. Journal Articles
- Minimal dataset for post‐registration surveillance of new drugs in hemophilia: communication from the SSC of the ISTH Journal Articles
- Mortality in vitamin K antagonist-related intracerebral bleeding treated with plasma or 4-factor prothrombin complex concentrate Journal Articles
- Musculoskeletal health of subjects with hemophilia A treated with tailored prophylaxis: Canadian Hemophilia Primary Prophylaxis (CHPS) Study Journal Articles
- Occurrence of inhibitors in previously untreated or minimally treated patients with haemophilia A after exposure to a plasma‐derived solvent‐detergent factor VIII concentrate Journal Articles
- Optimizing the safety of treatment for venous thromboembolism in the era of the direct oral anticoagulants Journal Articles
- Prothrombin Complex Concentrate for Major Bleeding on Factor Xa Inhibitors: A Prospective Cohort Study Journal Articles
- Recommendations for authors of manuscripts reporting inhibitor cases developed in previously treated patients with hemophilia: communication from the SSC of the ISTH Journal Articles
- Responses to Aggregating Agents after Cleavage of GPIb of Human Platelets by the O-Sialoglycoprotein Endoprotease from Pasteurella haemolytica— Potential Surrogates for Bernard-Soulier Platelets? \textbar Request PDF Other
- Reversal agents for non-vitamin K antagonist oral anticoagulants Journal Articles
- Safety and efficacy of sucrose-formulated full-length recombinant factor VIII: Experience in the standard clinical setting Journal Articles
- Simoctocog Alfa (Nuwiq) in Previously Untreated Patients with Severe Haemophilia A: Final Results of the NuProtect Study Journal Articles
- Specific antidotes for bleeding associated with direct oral anticoagulants Journal Articles
- Thromboembolic safety and efficacy of prothrombin complex concentrates in the emergency reversal of warfarin coagulopathy Journal Articles
- Using Value-of-Information Methods when the Disease Is Rare and the Treatment Is Expensive—The Example of Hemophilia A Journal Articles
- When and how to use antidotes for the reversal of direct oral anticoagulants: guidance from the SSC of the ISTH Journal Articles
- Zinc promotes clot stability by accelerating clot formation and modifying fibrin structure Journal Articles